BN Business News
Add your company to Business Communicator →

Regulation & law · 28/09/2018

National Cancer Institute to Grant Exclusive Patent License to Tailored Therapeutics for Cancer Cell Therapies

The National Cancer Institute, part of the National Institutes of Health, Department of Health and Human Services, is considering granting an exclusive patent license to Tailored Therapeutics, LLC, for the development and commercialization of cancer cell therapies.

Original source language: Federal Register — All DocumentsOpen original release →

Explore insights